ETFs Fresenius SE & Co. KGaA

Equities

FRE

DE0005785604

Healthcare Facilities & Services

Market Closed - Xetra 11:35:10 2024-07-12 am EDT 5-day change 1st Jan Change
29.35 EUR +0.38% Intraday chart for Fresenius SE & Co. KGaA +0.86% +4.56%

ETFs positioned on Fresenius SE & Co. KGaA

Name Weight AuM 1st Jan change Investor Rating
1.26% 2 M€ +13.56% -
1.05% 962 M€ -.--% -
1.01% 79 M€ -.--%
0.86% 5 M€ +10.09% -
0.86% 14 M€ +5.66% -
0.46% 21 M€ +11.32% -
0.21% 1,056 M€ +4.47%
0.16% 6 M€ -.--% -
0.13% 6 M€ -.--%
0.09% 7 M€ +8.00% -
0.07% 10 M€ -3.35% -
0.04% 35 M€ +8.73% -
0.03% 607 M€ +0.05% -
0.03% 1,166 M€ +0.26% -
0.03% 23 M€ -.--% -
0.03% 786 M€ -.--%
0.03% 288 M€ +28.23%
0.02% 206 M€ -.--%
0.02% 205 M€ -.--%
0.02% 284 M€ -.--%
0.02% 0 M€ 0.00% -
0.02% 414 M€ +13.30% -
0.01% 36 M€ +11.84% -
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
29.35 EUR
Average target price
37.54 EUR
Spread / Average Target
+27.90%
Consensus
  1. Stock Market
  2. Equities
  3. FRE Stock
  4. ETFs Fresenius SE & Co. KGaA